4-[6-[4-[[4-[[4-[3-cyano-4-[6-[4-[(2-methoxypyrimidin-5-yl)methyl]piperazin-1-yl]-3-pyridinyl]pyrazolo[1,5-a]pyrazin-6-yl]pyrazol-1-yl]methyl]pyrimidin-2-yl]methyl]piperazin-1-yl]-3-pyridinyl]-6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine-3-carbonitrile
C51H46N22O — CID 170182683
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[6-[4-[[4-[[4-[3-cyano-4-[6-[4-[(2-methoxypyrimidin-5-yl)methyl]piperazin-1-yl]-3-pyridinyl]pyrazolo[1,5-a]pyrazin-6-yl]pyrazol-1-yl]methyl]pyrimidin-2-yl]methyl]piperazin-1-yl]-3-pyridinyl]-6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine-3-carbonitrile
4-[6-[4-[[4-[[4-[3-cyano-4-[6-[4-[(2-methoxypyrimidin-5-yl)methyl]piperazin-1-yl]-3-pyridinyl]pyrazolo[1,5-a]pyrazin-6-yl]pyrazol-1-yl]methyl]pyrimidin-2-yl]methyl]piperazin-1-yl]-3-pyridinyl]-6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine-3-carbonitrile (PubChem CID 170182683) has the molecular formula C51H46N22O and a molecular weight of 983.08 g/mol. Its IUPAC name is 4-[6-[4-[[4-[[4-[3-cyano-4-[6-[4-[(2-methoxypyrimidin-5-yl)methyl]piperazin-1-yl]-3-pyridinyl]pyrazolo[1,5-a]pyrazin-6-yl]pyrazol-1-yl]methyl]pyrimidin-2-yl]methyl]piperazin-1-yl]-3-pyridinyl]-6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine-3-carbonitrile.
Molecular Properties
| Compound Name | 4-[6-[4-[[4-[[4-[3-cyano-4-[6-[4-[(2-methoxypyrimidin-5-yl)methyl]piperazin-1-yl]-3-pyridinyl]pyrazolo[1,5-a]pyrazin-6-yl]pyrazol-1-yl]methyl]pyrimidin-2-yl]methyl]piperazin-1-yl]-3-pyridinyl]-6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine-3-carbonitrile |
|---|---|
| PubChem CID | 170182683 |
| Molecular Formula | C51H46N22O |
| Molecular Weight | 983.08 g/mol |
| Exact Mass | 982.42 |
| IUPAC Name | 4-[6-[4-[[4-[[4-[3-cyano-4-[6-[4-[(2-methoxypyrimidin-5-yl)methyl]piperazin-1-yl]-3-pyridinyl]pyrazolo[1,5-a]pyrazin-6-yl]pyrazol-1-yl]methyl]pyrimidin-2-yl]methyl]piperazin-1-yl]-3-pyridinyl]-6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine-3-carbonitrile |
| SMILES | COc1ncc(CN2CCN(c3ccc(-c4nc(-c5cnn(Cc6ccnc(CN7CCN(c8ccc(-c9nc(-c%10cnn(C)c%10)cn%10ncc(C#N)c9%10)cn8)CC7)n6)c5)cn5ncc(C#N)c45)cn3)CC2)cn1 |
| InChI | InChI=1S/C51H46N22O/c1-66-28-39(25-59-66)42-31-72-49(37(17-52)23-61-72)47(64-42)35-3-6-46(56-21-35)70-15-11-68(12-16-70)33-44-54-8-7-41(63-44)30-71-29-40(26-60-71)43-32-73-50(38(18-53)24-62-73)48(65-43)36-4-5-45(55-22-36)69-13-9-67(10-14-69)27-34-19-57-51(74-2)58-20-34/h3-8,19-26,28-29,31-32H,9-16,27,30,33H2,1-2H3 |
| InChIKey | LOELKIRUTQHPEI-UHFFFAOYSA-N |
| XLogP | 4.18 |
| TPSA | 243.13 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 23 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 74 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 983.08 |
| LogP ≤ 5 | 4.18 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 23 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 170182683 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.